566 related articles for article (PubMed ID: 16493048)
21. A CXCR4-dependent chemorepellent signal contributes to the emigration of mature single-positive CD4 cells from the fetal thymus.
Vianello F; Kraft P; Mok YT; Hart WK; White N; Poznansky MC
J Immunol; 2005 Oct; 175(8):5115-25. PubMed ID: 16210615
[TBL] [Abstract][Full Text] [Related]
22. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice.
Garcia-Hernandez Mde L; Hamada H; Reome JB; Misra SK; Tighe MP; Dutton RW
J Immunol; 2010 Apr; 184(8):4215-27. PubMed ID: 20237297
[TBL] [Abstract][Full Text] [Related]
23. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.
Zhang W; Okimura T; Xu L; Zhang L; Oda T; Kwak M; Yu Q; Jin JO
Oncotarget; 2016 Apr; 7(15):19284-98. PubMed ID: 27008707
[TBL] [Abstract][Full Text] [Related]
24. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
25. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH
Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534
[TBL] [Abstract][Full Text] [Related]
26. Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.
Haque M; Song J; Fino K; Sandhu P; Wang Y; Ni B; Fang D; Song J
Cell Transplant; 2016; 25(5):811-27. PubMed ID: 26777320
[TBL] [Abstract][Full Text] [Related]
27. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
[TBL] [Abstract][Full Text] [Related]
28. Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10.
Nishimura F; Dusak JE; Eguchi J; Zhu X; Gambotto A; Storkus WJ; Okada H
Cancer Res; 2006 Apr; 66(8):4478-87. PubMed ID: 16618775
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment.
Bathe OF; Dalyot-Herman N; Malek TR
BMC Cancer; 2003 Jul; 3():21. PubMed ID: 12882650
[TBL] [Abstract][Full Text] [Related]
30. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
[TBL] [Abstract][Full Text] [Related]
31. Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2000 Jan; 164(2):916-25. PubMed ID: 10623840
[TBL] [Abstract][Full Text] [Related]
32. CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity.
Zhang H; Xie Y; Li W; Chibbar R; Xiong S; Xiang J
Cell Mol Immunol; 2011 Jan; 8(1):23-30. PubMed ID: 21200381
[TBL] [Abstract][Full Text] [Related]
33. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes.
Hao S; Bai O; Yuan J; Qureshi M; Xiang J
Cell Mol Immunol; 2006 Jun; 3(3):205-11. PubMed ID: 16893501
[TBL] [Abstract][Full Text] [Related]
34. Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses.
Dunussi-Joannopoulos K; Zuberek K; Runyon K; Hawley RG; Wong A; Erickson J; Herrmann S; Leonard JP
Blood; 2002 Sep; 100(5):1551-8. PubMed ID: 12176869
[TBL] [Abstract][Full Text] [Related]
35. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.
Hornung RL; Longo DL; Bowersox OC; Kwak LW
J Natl Cancer Inst; 1995 Sep; 87(17):1289-96. PubMed ID: 7544833
[TBL] [Abstract][Full Text] [Related]
36. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
[TBL] [Abstract][Full Text] [Related]
37. NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12.
Garg B; Giri B; Modi S; Sethi V; Castro I; Umland O; Ban Y; Lavania S; Dawra R; Banerjee S; Vickers S; Merchant NB; Chen SX; Gilboa E; Ramakrishnan S; Saluja A; Dudeja V
Gastroenterology; 2018 Sep; 155(3):880-891.e8. PubMed ID: 29909021
[TBL] [Abstract][Full Text] [Related]
38. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
[TBL] [Abstract][Full Text] [Related]
39. TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR.
Peacock JW; Jirik FR
J Immunol; 1999 Jan; 162(1):215-23. PubMed ID: 9886389
[TBL] [Abstract][Full Text] [Related]
40. Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.
Stoitzner P; Green LK; Jung JY; Price KM; Atarea H; Kivell B; Ronchese F
Cancer Immunol Immunother; 2008 Nov; 57(11):1665-73. PubMed ID: 18311487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]